<DOC>
	<DOCNO>NCT02544802</DOCNO>
	<brief_summary>The purpose study evaluate safety preliminary efficacy autologous adipose-derived mesenchymal stem cell ( ADMSCs ) treatment patient primary osteoarthritis knee . Three intra-articular injection autologous ADMSCs perform subject weekly interval .</brief_summary>
	<brief_title>Mesenchymal Stem Cell Treatment Primary Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Subject bilateral Kellgren Lawrence grade IIIII primary osteoarthritis determine Xray . 2 . Subject 's pain score 813 point ( Lequesne 's index ) . 3 . Ages 5070 year . 4 . Signed informed consent subject . 5 . Female subject postmenopausal woman 1 . Subject infected hepatitis B , hepatitis C , HIV , syphilis HTLV . 2 . Subject suitable liposuction surgery . 3 . Subject hypersensitivity/allergy anesthetic . 4 . Subject 's creatinine value high 1.6mg/dl . 5 . Subject body mass index , BMI 30 . 6 . Subject 's studied knee treat intraarticular injection therapy within 6 month prior screen . 7 . Subject undergone surgery either side knee , include fracture surgery , arthroscopic surgery , meniscus repair surgery , cruciate ligament reconstruction surgery . 8 . Subject enrol cell therapy study within past 30 day . 9 . Subject investigator considers inappropriate clinical trial due reason list . 10 . Subject history gouty arthritis , septic arthritis , rheumatoid arthritis autoimmune arthritis knee joint . 11 . Subject major medical problem vital organ , ; heart , liver , kidney , lung .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>